SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VALGIMIGLI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.078
EU - Europa 391
AS - Asia 317
SA - Sud America 3
OC - Oceania 2
Totale 2.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.077
CN - Cina 193
UA - Ucraina 118
DE - Germania 78
GB - Regno Unito 58
SG - Singapore 53
TR - Turchia 53
SE - Svezia 35
IT - Italia 33
FI - Finlandia 25
BE - Belgio 9
FR - Francia 8
RU - Federazione Russa 8
ID - Indonesia 7
AL - Albania 5
IN - India 5
VN - Vietnam 5
CO - Colombia 3
CZ - Repubblica Ceca 3
ES - Italia 3
IE - Irlanda 2
RO - Romania 2
AU - Australia 1
DK - Danimarca 1
GR - Grecia 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.791
Salva come PNG Salva come JPEG
Città #
Fairfield 282
Woodbridge 280
Ann Arbor 164
Ashburn 154
Chandler 149
Houston 132
Jacksonville 126
Seattle 111
Wilmington 106
Cambridge 65
New York 57
Beijing 51
Princeton 42
Izmir 37
Nanjing 33
Singapore 30
San Diego 29
Bremen 25
Shanghai 21
Boardman 20
Milan 15
Jiaxing 13
Redwood City 13
Shenyang 13
Dearborn 11
Changsha 10
Nanchang 10
Brussels 9
Los Angeles 8
Tianjin 8
Ferrara 7
Jakarta 7
Jinan 7
Leawood 7
Washington 7
Auburn Hills 6
Norwalk 6
San Mateo 6
Dong Ket 5
London 5
Mountain View 5
Augusta 4
Falls Church 4
Zhengzhou 4
Addison 3
Hangzhou 3
Indiana 3
Kunming 3
New Haven 3
Ningbo 3
Philadelphia 3
Tappahannock 3
Chicago 2
Como 2
Dublin 2
Hebei 2
Hefei 2
Hounslow 2
Kilburn 2
Lanzhou 2
Moscow 2
Olomouc 2
Taizhou 2
Tucson 2
Verona 2
Acton 1
Ardabil 1
Barcelona 1
Bogotá 1
Bologna 1
Bratislava 1
Brno 1
Changchun 1
Copenhagen 1
Cuauhtémoc 1
Des Moines 1
Guangzhou 1
Haikou 1
Kumar 1
Monmouth Junction 1
Mumbai 1
Munich 1
Nashville 1
Nelson 1
New Delhi 1
Nizhniy Novgorod 1
Perth 1
Pomona 1
Pontevedra 1
Redmond 1
San Francisco 1
Southwark 1
St Petersburg 1
Stockholm 1
Tirana 1
Walnut 1
Yellow Springs 1
Totale 2.186
Salva come PNG Salva come JPEG
Nome #
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 143
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 136
Poor response to clopidogrel: current and future options for its management 130
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 128
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 121
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 114
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 110
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 108
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 108
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 106
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 106
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 105
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 103
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 80
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial 80
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial 80
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trial 72
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 70
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 69
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 69
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 69
Cohort profile The ESC-EORP Chronic Ischemic Cardiovascular Disease Long-Term (CICD LT) registry 68
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. 64
Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients 64
Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy 64
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 63
null 61
null 61
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 59
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Insights From the EXAMINATION Trial 53
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies—meta-analysis of prospective studies 44
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 25
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 24
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 24
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI 20
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 20
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 18
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 11
Stable angina pectoris 11
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 8
Totale 2.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020664 99 30 18 79 33 78 66 72 60 74 43 12
2020/2021413 33 36 16 44 20 40 19 50 7 50 68 30
2021/2022441 16 50 53 20 22 14 35 26 14 32 48 111
2022/2023353 45 5 19 48 66 56 9 29 45 8 16 7
2023/2024272 25 24 11 8 17 81 10 13 5 8 5 65
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 2.869